Nociceptin/orphanin FQ and related peptides reduce the increase in plasma corticosterone elicited in mice by an intracerebroventricular injection

Life Sciences

Volumn 72, Issue 2, 2002, Pages 163-171

  Le Cudennec, C ^a   Naudin, B ^a   Do Rego, J C ^a   Costentin, J ^a  

^a UNIVERSITÉ DE ROUEN   (France)

Author keywords

Corticosterone; Intracerebroventricular injection; N OFQ(1 13)NH2; Stress; Nphe1 N OFQ(1 13)NH2; Phe1 (CH NH2) Gly2 N OFQ(1 13)NH2

Indexed keywords

CORTICOSTERONE; NOCICEPTIN; NOCICEPTIN RECEPTOR; NOCICEPTIN RECEPTOR AGONIST; NOCICEPTIN RECEPTOR ANTAGONIST; NOCICEPTIN[1-13]AMIDE; NOCICEPTIN[1-13]AMIDE[1 NORPHENYLALANINE]; PSEUDOPEPTIDE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; CORTICOSTERONE BLOOD LEVEL; DRUG EFFECT; DRUG SELECTIVITY; MALE; MOUSE; NONHUMAN; RECEPTOR BLOCKING; STRESS;

ANIMALS; CORTICOSTERONE; DOSE-RESPONSE RELATIONSHIP, DRUG; HANDLING (PSYCHOLOGY); INJECTIONS, INTRAVENTRICULAR; MALE; MICE; OPIOID PEPTIDES; RECEPTORS, OPIOID;

RODENTIA;

EID: 0037195554     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0024-3205(02)02218-X     Document Type: Article

References (47)

1. Mollereau C., Parmentier M., Mailleux P., Butour J.L., Moisand C., Chalon P., Caput D., Vassart G., Meunier J.C. ORL1, a novel member of the opioid receptor family: cloning, functional expression and localization. F.E.B.S. Letters. 341:1994;33-38.
2. Cox B.M., Chavkin C., Christie M.J., Civelli O., Evans C., Hamon M.D., Hoellt V., Kieffer B., Kitchen I., McKnight A.T., Meunier J.C., Portoghese P.S. Opioid receptors. Girdlestone D. The IUPHAR Compendium of Receptor Characterisation and classification. 2000;321-333 IUPHAR Media Ltd, London.
3. Meunier J.C., Mollereau C., Toll L., Suaudeau C., Moisand C., Alvinerie P., Butour J.L., Guillemot J.C., Ferrara P., Monsarrat B., Mazarguil H., Vassart G., Parmentier M., Costentin J. Isolation and structure of the endogenous agonist of opioid receptor-like ORL1 receptor. Nature. 377:1995;532-535.
4. Reinscheid R.K., Nothaker H.P., Bourson A., Ardati A., Henningsen R.A., Bunzow J.R., Grandy D.K., Langen H., Monsma F.J. Jr., Civelli O. Orphanin FQ: a neuropeptide that activates an opioid like G protein-coupled receptor. Science. 270:1995;792-794.
5. Nishi M., Houtani T., Noda Y., Mamiya T., Sato K., Doi T., Kuno J., Takeshima H., Nukada T., Nabeshima T., Yamashita T., Noda T., Sugimoto T. Unrestrained nociceptive response and disregulation of hearing ability in mice lacking the nociceptin/orphaninFQ receptor. E.M.B.O. Journal. 16(8):1997;1858-1864.
6. Suaudeau C., Florin S., Meunier J.C., Costentin J. Nociceptin-induced apparent hyperalgesia in mice as a result of the prevention of opioid autoanalgesic mechanisms triggered by the stress of an intracerebroventricular injection. Fundamental & Clinical Pharmacology. 12(4):1998;420-425.
7. Okuda-Ashitaka E., Tachibana S., Houtani T., Minami T., Masu Y., Nishi M., Takeshima H., Sugimoto T., Ito S. Identification and characterization of an endogenous ligand for opioid receptor homologue ROR-C: its involvement in allodynic response to innocuous stimulus. Molecular Brain Research. 43(1-2):1996;96-104.
8. Xu X.J., Hao J.X., Wiesenfeld-Hallin Z. Nociceptin or antinociceptin: potent spinal antinociceptive effect of orphanin FQ/nociceptin in the rat. Neuroreport. 7(13):1996;2092-2094.
9. King M.A., Rossi G.C., Chang A.H., Williams L., Pasternak G.W. Spinal analgesic activity of orphanin FQ/nociceptin and its fragments. Neuroscience Letters. 223(2):1997;113-116.
10. Florin S., Suaudeau C., Meunier J.C., Costentin J. Nociceptin stimulates locomotion and exploratory behaviour in mice. European Journal of Pharmacology. 317:1996;9-13.
11. Pomonis J.D., Billington C.J., Levine A.S. Orphanin FQ, agonist of orphan opioid receptor ORL1, stimulates feeding in rats. NeuroReport. 8:1996;369-371.
12. Stratford T.R., Holahan M.R., Kelley A.E. Injections of nociceptin into nucleus accumbens shell or ventromedial hypothalamic nucleus increase food intake. NeuroReport. 8:1997;423-426.
13. Polidori C., de Caro G., Massi M. The hyperphagic effect of nociceptin/orphanin FQ in rats. Peptides. 21(7):2000;1051-1062.
14. Griebel G., Perrault G., Sanger D.J. Orphanin FQ, a novel neuropeptide with anti-stress-like activity. Brain Research. 836(1-2):1999;221-224.
15. Jenck F., Moreau J.L., Martin J.R., Kilpatrick G.J., Reinscheid R.K., Monsma F.J. Jr., Nothacker H.P., Civelli O. Orphanin FQ acts as an anxiolytic to attenuate behavioral responses to stress. P.N.A.S. U.S.A. 94(26):1997;14854-14858.
16. Mogil J.S., Grisel J.E., Reinscheid R.K., Civelli O., Belknap J.K., Grandy D.K. Orphanin FQ is a functional anti-opioid peptide. Neuroscience. 75(2):1996;333-337.
17. Koster A., Montkowski A., Schulz S., Stube E.M., Knaudt K., Jenck F., Moreau J.L., Nothacker H.P., Civelli O., Reinscheid R.K. Targeted disruption of the orphanin FQ/nociceptin gene increases stress susceptibility and impairs stress adaptation in mice. P.N.A.S. U.S.A. 96(18):1999;10444-10449.
18. Florin S., Leroux-Nicollet I., Meunier J.C., Costentin J. Autoradiographic localization of [3H]nociceptin binding sites from telencephalic to mesencephalic regions of the mouse brain. Neuroscience Letters. 230(1):1997;33-36.
19. Neal C.R. Jr., Mansour A., Reinscheid R., Nothaker H.P., Civelli O., Watson S.J. Jr. Localization of orphanin FQ (nociceptin) peptide and messenger RNA in the central nervous system of the rat. Journal of Comparative Neurology. 406(4):1999;503-547.
20. Bunzow J.R., Saez C., Mortrud M., Bouvier C., Williams J.T., Low M., Grandy D.K. Molecular cloning and tissue distribution of a putative member of the rat opioid receptor gene family that is not a μ, δ or κ opioid receptor type. F.E.B.S. Letters. 347:1994;284-288.
21. Fukuda K., Kato S., Mori K., Nishi M., Takeshima H., Iwabe N., Miyata T., Houtani T., Sugimoto T. cDNA cloning and regional distribution of a novel member of the opioid receptor family. F.E.B.S. Letters. 343:1994;42-46.
22. Wick M.J., Minnerath S.R., Lin X., Elde R., Law P.Y., Loth H.H. Isolation of a novel cDNA encoding a putative membrane receptor with high homology to the cloned μ, δ and κ opioid receptors. Molecular Brain Research. 27:1994;37-44.
23. Calo G., Rizzi A., Bogoni G., Neugebauer V., Salvadori S., Guerrini R., Bianchi C., Regoli D. The mouse vas deferens: a pharmacological preparation sensitive to nociceptin. European Journal of Pharmacology. 311(1):1996;R3-R5.
24. Guerrini R., Girolamo C., Rizzi A., Bigoni R., Bianchi C., Salvadori S., Regoli D. A new selective antagonist of the nociceptin receptor. British Journal of Pharmacology. 123:1998;163-165.
25. Calo G., Guerrini R., Bigoni R., Rizzi A., Marzola G., Okawa H., Bianchi C., Lambert D.G., Salvadori S., Regoli D. Characterization of [Nphe(1)]nociceptin(1-13)NH(2), a new selective nociceptin receptor antagonist. Br J Pharmacol. 129(6):2000;1183-1193.
26. Guerrini R., Calo G., Rizzi A., Bianchi C., Lazarus L.H., Salvadori S., Temussi P.A., Regoli D. Address and message sequences for the nociceptin receptor: a structure-activity study of nociceptin-(1-13)-peptide amide. Journal of Medicinal Chemistry. 40(12):1997;1789-1793.
27. Calo G., Bigoni R., Rizzi A., Guerrini R., Salvadori S., Regoli D. Nociceptin/orphanin FQ receptor ligands. Peptides. 21(7):2000;935-947.
28. Calo G., Guerrini R., Bigoni R., Rizzi A., Bianchi C., Regoli D., Salvadori S. Structure-activity study of the nociceptin(1-13)-NH2 N-terminal tetrapeptide and discovery of a nociceptin receptor antagonist. Journal of Medicinal Chemistry. 41(18):1998;3360-3366.
29. 2]nociceptin-(1-13)- NH2 is an agonist of the nociceptin (ORL1) receptor. European Journal of Pharmacology. 349(1):1998;R5-R6.
30. 2]nociceptin-(1-13)- NH2, a peripheral ORL-1 receptor antagonist, acts as an agonist in the rat spinal cord. British Journal of Pharmacology. 125(5):1998;949-951.
31. 2 in the mouse and rat colon and the mouse vas deferens. European Journal of Pharmacology. 385:1999;217-223.
32. Olianas M.C., Maullu C., Ingianni A., Onali P. [Phe1phi(CH2-NH)Gly2]nociceptin-(1-13)-NH2 acts as a partial agonist at ORL1 receptor endogenously expressed in mouse N1E-115 neuroblastoma cells. Neuroreport. 10(5):1999;1127-1131.
33. 2 antagonizes nociceptin effects in the mouse colon. Eur J Pharmacol. 385(2-3):1999;R3-R5.
34. 2, a nociceptin receptor antagonist, reverses nociceptin-induced spatial memory impairments in the Morris water maze task in rats. Br J Pharmacol. 131(7):2000;1379-1384.
35. 2 selectively reduces the spinal inhibitory effect of nociceptin. Life Sciences. 70:2002;1151-1157.
36. 2.
37. 2 selectively antagonizes nociceptin/orphanin FQ-stimulated G-protein activation in rat brain. J Pharmacol Exp Ther. 294(2):2000;428-433.
38. Haley J.J., Mc. Cornick N.G. Pharmacological effects producted by intracerebral injection of drugs in conscious mice. British Journal of Pharmacology. 12:1957;12-15.
39. Devine D.P., Watson S.J., Akil H. Nociceptin/orphanin FQ regulates neuroendocrine function of the limbic-hypothalamic-pituitary-adrenal axis. Neuroscience. 102(3):2001;541-553.
40. Burnside J.L., Rodriguez L., Toll L. Species differences in the efficacy of compounds at the nociceptin receptor (ORL1). Peptides. 21(7):2000;1147-1154.
41. Eisenberg R.M. Plasma corticosterone changes in response to central or peripheral administration of kappa and sigma opiate agonists. Journal of Pharmacology and Experimental Therapeutics. 233(3):1985;863-869.
42. Pechnick R., George R., Poland R.E. Identification of multiple opiate receptors through neuroendocrine responses. I. Effects of agonists. Journal of Pharmacology and Experimental Therapeutics. 232(1):1984;163-169.
43. Hayes A.G., Stewart B.R. Effect of μ and κ opioid receptor agonists on plasma corticosterone levels. European Journal of Pharmacology. 116:1985;75-79.
44. Abercrombie E.D., Keller R.W., Zigmond M.J. Characterization of hippocampal norepinephrine release as measured by microdialysis perfusion: pharmacological and behavioral studies. Neuroscience. 27(3):1988;897-904.
45. Laorden M.L., Milanes M.V. Effects of U-50,488H and U-50,488H withdrawal on catecholaminergic neurons of the rat hypothalamus. Life Sciences. 66(9):1999;803-815.
46. Ciccocioppo R., Martin-Fardon R., Weiss F., Massi M. Nociceptin/orphanin FQ inhibits stress- and CRF-induced anorexia in rats. Neuroreport. 12(6):2001;1145-1149.
47. Werthwein S., Bauer U., Nakazi M., Kathmann M., Schlicker E. Further characterization of the ORL1 receptor-mediated inhibition of noradrenaline release in the mouse brain in vitro. British Journal of Pharmacology. 127(1):1999;300-308.